Penetration of ciprofloxacin into the interstitial space of inflamed foot lesions in non-insulin-dependent diabetes mellitus patients

被引:69
作者
Müller, M
Brunner, M
Hollenstein, U
Joukhadar, C
Schmid, R
Minar, E
Ehringer, H
Eichler, HG
机构
[1] Univ Vienna, Sch Med, Dept Clin Pharmacol, Div Infect Dis & Chemotherapy, Vienna, Austria
[2] Univ Vienna, Sch Med, Dept Internal Med 1, Div Infect Dis & Chemotherapy, Vienna, Austria
[3] Univ Vienna, Sch Med, Dept Med & Chem Lab Diag, Vienna, Austria
[4] Univ Vienna, Sch Med, Dept Internal Med 2, Div Angiol, Vienna, Austria
关键词
D O I
10.1128/AAC.43.8.2056
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Interstitial ciprofloxacin concentrations were measured by microdialysis in inflamed foot lesions of noninsulin-dependent diabetes mellitus patients following intravenous administration of 0.2 g of ciprofloxacin. Interstitial ciprofloxacin concentrations were significantly lower than corresponding serum concentrations. There was no significant difference in the penetration of ciprofloxacin into inflamed and unaffected tissue (area under the concentration-time curve(infection)/area under the concentration-time curve(unaffected tissue) = 0.99 +/- 0.15 [mean +/- standard error], n = 6). Thus, inflammation appears to have little or no effect on the penetration of ciprofloxacin into tissue.
引用
收藏
页码:2056 / 2058
页数:3
相关论文
共 24 条
[1]   CLINICAL-EXPERIENCE WITH CIPROFLOXACIN IN THE USA [J].
ARCIERI, G ;
AUGUST, R ;
BECKER, N ;
DOYLE, C ;
GRIFFITH, E ;
GRUENWALDT, G ;
HEYD, A ;
OBRIEN, B .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1986, 5 (02) :220-225
[2]   Distribution and antimicrobial activity of ciprofloxacin in human soft tissues [J].
Brunner, M ;
Hollenstein, U ;
Delacher, S ;
Jäger, D ;
Schmid, R ;
Lackner, E ;
Georgopoulos, A ;
Eichler, HG ;
Müller, M .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (05) :1307-1309
[3]   Tissue concentration of clindamycin and gentamicin near ischaemic ulcers with transvenous injection in Bier's arterial arrest [J].
Burgmann, H ;
Georgopoulos, A ;
Graninger, W ;
Koppensteiner, R ;
Maca, T ;
Minar, E ;
Schneider, B ;
Stumpflen, A ;
Ehringer, H .
LANCET, 1996, 348 (9030) :781-783
[4]   PHARMACOKINETICS AND PHARMACODYNAMICS OF NEUTROPHIL-ASSOCIATED CIPROFLOXACIN IN HUMANS [J].
CAPECCHI, PL ;
BLARDI, P ;
DELALLA, A ;
CECCATELLI, L ;
VOLPI, L ;
PASINI, FL ;
DIPERRI, T .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1995, 57 (04) :446-454
[5]   THE PENETRATION OF CIPROFLOXACIN INTO BRONCHIAL-MUCOSA, LUNG PARENCHYMA, AND PLEURAL TISSUE AFTER INTRAVENOUS ADMINISTRATION [J].
DAN, M ;
TOROSSIAN, K ;
WEISSBERG, D ;
KITZES, R .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1993, 44 (01) :101-102
[6]   TREATMENT OF SKIN AND SOFT-TISSUE INFECTIONS WITH ORAL CIPROFLOXACIN [J].
FASS, RJ .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1986, 18 :153-157
[7]   CIPROFLOXACIN CONCENTRATIONS IN BONE AND MUSCLE AFTER ORAL DOSING [J].
FONG, IW ;
LEDBETTER, WH ;
VANDENBROUCKE, AC ;
SIMBUL, M ;
RAHM, V .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1986, 29 (03) :405-408
[8]  
GIBONS GW, 1984, MANAGEMENT DIABETIC, P97
[9]   THE IMPORTANCE OF PHARMACOKINETIC-PHARMACODYNAMIC SURROGATE MARKERS TO OUTCOME - FOCUS ON ANTIBACTERIAL AGENTS [J].
HYATT, JM ;
MCKINNON, PS ;
ZIMMER, GS ;
SCHENTAG, JJ .
CLINICAL PHARMACOKINETICS, 1995, 28 (02) :143-160
[10]   HPLC analysis of ciprofloxacin and ciprofloxacin metabolites in body fluids [J].
Krol, GJ ;
Beck, GW ;
Benham, T .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1995, 14 (1-2) :181-190